Central, Eastern Europe Lead OTC Growth On Sector's Top Continent
This article was originally published in PharmAsia News
Central and Eastern Europe continue to drive OTC sales growth on the continent, with even low-growth countries matching the best levels in Western Europe
You may also be interested in...
GlaxoSmithKline will divest non-core OTC products to accelerate consumer health care growth and help fund a share buy-back program following a financial wipeout in the firm's most recent quarter.
Sanofi-Aventis further expands its consumer product business with a $130.4 million offer for Polish drug, dietary supplement and cosmetics firm Nepentes Group
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).